Time-release form of active vitamin D granted a patent for chronic kidney disease – July 2014

OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE

  • Treat secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
  • US Pat. No. 8,778,373

Notes by VitaminDWiki

  1. Standard vitamin D is not available to much of the body when the kidney is not working
  2. Standard active vitamin D has a very short half life, so time release form should be an excellent improvement - see other options below

See also VitaminDWiki

See also web


Image

8470 visitors, last modified 26 Jul, 2015,
Printer Friendly Follow this page for updates